Imagin Medical LOGO.jpg
Imagin Medical on Schedule for American Urology Association Demonstration
August 17, 2021 08:30 ET | Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the...
LogoPressRelease.jpg
Fluidigm to Participate in UBS Genomics 2.0 and MedTech Innovations Summit
August 09, 2021 11:14 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
TeraRecon Announces Dan McSweeney President_Press Release Social Media Image_June 15, 2021
Symphony AI Company TeraRecon Appoints Dan McSweeney President
June 24, 2021 06:00 ET | TeraRecon, Inc
DURHAM, N.C., June 24, 2021 (GLOBE NEWSWIRE) -- Advanced visualization and AI leader TeraRecon, a SymphonyAI company, today announced the appointment of Dan McSweeney as president. He will be...
Imagin Medical LOGO.jpg
IMAGIN MEDICAL REPORTS COMPANY ON SCHEDULE FOR PRODUCT DEMONSTRATION
May 19, 2021 08:30 ET | Imagin Medical Inc.
Vancouver, B.C. and Boston, MA, May 19, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the...
LogoPressRelease.jpg
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time
May 10, 2021 13:30 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
LogoPressRelease.jpg
Fluidigm Announces First Quarter 2021 Financial Results with Total Revenue of $32.8 Million, Up 19 Percent Over Prior Year Period
May 06, 2021 16:05 ET | Fluidigm Corporation
Forecasting underlying base business growth of 16–17% supported by new product innovation SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an...
Luminate.png
Empire State Development Announces the 10 Finalists Selected for Round 4 of Luminate NY Accelerator Competition
March 16, 2021 11:28 ET | Luminate
$25 Million Luminate NY Initiative Continues to Bring the Best Startups with Optics, Photonics, and Imaging Technologies to the Finger Lakes Region to Tap World Class Resources and Grow the Economy ...
Imagin Medical LOGO.jpg
IMAGIN MEDICAL CLOSES SECOND TRANCHE OF CONVERTIBLE NOTE OFFERING
February 18, 2021 08:30 ET | Imagin Medical Inc.
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the...
Imagin Medical LOGO.jpg
Imagin Medical Engages Torrey Hills Capital
January 20, 2021 08:30 ET | Imagin Medical Inc.
VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to...
LogoPressRelease.jpg
Fluidigm Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Financial Results
January 07, 2021 16:02 ET | Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...